Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;30(5):1555-1567.
doi: 10.1007/s10787-022-01051-6. Epub 2022 Aug 27.

Exploring the pivotal role of endothelin in rheumatoid arthritis

Affiliations
Review

Exploring the pivotal role of endothelin in rheumatoid arthritis

Aayush Sehgal et al. Inflammopharmacology. 2022 Oct.

Abstract

A chronic inflammatory disorder, rheumatoid arthritis (RA) is an autoimmune and systemic disease characterized by progressive and prolonged destruction of joints. This results in increased mortality, physical disability and destruction. Cardiovascular disorders are one of the primary causes of mortality in patients with RA. It is multifactorial in nature and includes genetic, environmental and demographic factors which contribute to the severity of disease. Endothelin-1 (ET-1) is a peptide which acts as a potent vasoconstrictor and is generated through vascular smooth muscle and endothelial cells. Endothelins may be responsible for RA, as under certain circumstances they produce reactive oxygen species which further promote the production of pro-inflammatory cytokines. This enhances the production of superoxide anion, which activates pro-inflammatory cytokines, resulting in RA. The aim of this review is to elucidate the role of endothelin in the progression of RA. This review also summarizes the natural and synthetic anti-inflammatory drugs which have provided remarkable insights in targeting endothelin.

Keywords: Chronic inflammation; Endothelins; Interleukins; Pro-inflammatory cytokines; Rheumatoid arthritis.

PubMed Disclaimer

References

    1. Alvarez-Cienfuegos A, Cantero-Nieto L, García-Gómez JA, Ríos-Fernández R, Martín J, González-Gay MA, Ortego-Centeno N. (2019). Endothelin-1 serum levels in women with rheumatoid arthritis. Acta Reumatol Port 44:250–257. http://hdl.handle.net/10261/226842
    1. Amin AR, Di Cesare PE, Vyas P, Attur M, Tzeng E, Billiar TR, Stuchin SA, Abramson SB (1995) The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase. J Exp Med 182:2097–2102. https://doi.org/10.1084/jem.182.6.2097 - DOI - PubMed
    1. Bagnato A, Tecce R, Di Castro V, Catt KJ (1997) Activation of mitogenic signaling by endothelin 1 in ovarian carcinoma cells. Cancer Res 57:1306–1311 - PubMed
    1. Bakrania B, Duncan J, Warrington JP, Granger JP (2017) The endothelin type A receptor as a potential therapeutic target in preeclampsia. Int J Mol Sci 18:522. https://doi.org/10.3390/ijms18030522 - DOI - PMC
    1. Batumalaie K, Amin MA, Murugan DD, Sattar MZ, Abdullah NA, Withaferin A (2016) Protects against palmitic acid-induced endothelial insulin resistance and dysfunction through suppression of oxidative stress and inflammation. Sci Rep. https://doi.org/10.1038/srep27236 (PMID: 27250532; PMCID: PMC4890118) - DOI - PubMed - PMC

LinkOut - more resources